Purpose: It has been suggested that female sex steroids have neuroprotective properties that may reduce risk of glaucoma in premenopausal women. In this study, we explored the associations of optic disc measures with female reproductive factors in a population of young women.
W
orldwide, there is a clear imbalance in the incidence of age-related eye diseases and visual impairment between men and women, with approximately twice the number of women suffering from blindness compared with men. [1] [2] [3] Although sociodemographic factors such as women's relative longevity and restricted access to healthcare may partly explain this discrepancy, 4 there is increasing evidence that hormonal factors may have a significant role in ocular health. 4, 5 Researchers have hypothesized that the antioxidative, neuroprotective, and vasodilation properties of female sex steroid, [6] [7] [8] [9] including estrogens and progesterone, may protect against the development and progression of eye diseases in women during their premenopausal years. 4 However, with the onset of natural menopause, endogenous estrogen levels gradually decline, and this withdrawal of the protective effect of sex hormone may increase women's susceptibility to certain ocular diseases. 4 With surgically induced menopause, the decline in female sex steroid levels is abrupt and has been suggested to increase glaucoma risk in women younger than 43 years. 10 Indeed, glaucoma risk has been reported to be lower with longer duration of endogenous estrogen exposure, as determined by younger age at menarche 11, 12 and/or later age at menopause. 11, [13] [14] [15] In addition, female sex steroids have also been shown to influence intraocular pressure (IOP), 6, 16 with postmenopausal women tending to have higher IOPs than their age-matched premenopausal counterparts. 6 Some studies have even reported that IOP is reduced after initiation of hormone replacement therapy in postmenopausal women with 16 and without glaucoma. 6, 17, 18 Given this association between levels of endogenous female sex steroids and glaucoma in older women, it may be possible to predict a woman's susceptibility to the disease based on factors that affected her sex steroid levels during her younger years. Because exposure to significant levels of endogenous female sex steroids starts around menarche 19 and can be affected by parity and the use of hormonal contraceptives, 19 ocular structures may have been influenced by these female reproductive factors since adolescence. In glaucoma, the main ocular structure of interest is the optic disc; optic disc parameters at baseline (ie,
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Reproductive Factors in Young Women before the onset of glaucoma) may therefore provide important information regarding an individual's risk of developing the disease. 20 However, although many studies have described a link between increased endogenous estrogen exposure and decreased glaucoma risk in older women, [11] [12] [13] 15 none has explored how female reproductive factors, especially those that are known to influence levels of female sex steroids, may be associated with glaucoma-related optic disc parameters, particularly in younger women. This study explored the associations between optic disc parameters and female reproductive factors in a cohort of young and healthy women.
METHODS

Study Participants
Young women were recruited as part of the Western Australian Pregnancy Cohort (Raine) Study; the detailed methodology has been described previously. [21] [22] [23] In brief, from a cohort of 2900 pregnant women, 2686 offspring were born between May 1989 and November 1991. These offspring have been undergoing a series of medical tests and questionnaires at various ages. At the 20-year follow-up, 1344 of these offspring attended an ophthalmic assessment, 22 and 654 (48.7%) of them were women. All participants were given a full explanation of the nature of the study and provided informed consent before participation. The study was conducted in accordance with the tenets of the Declaration of Helsinki, and ethical approval for each follow-up was obtained from the University of Western Australia's Human Research Ethics Committee.
Female Reproductive Factors
At the 13-, 16-, and 20-year follow-ups, participants completed self-administered questionnaires that obtained information on their pubertal and sexual health, including the age of their first menstrual period (age at menarche), duration of menstrual cycle, past and current methods of hormonal contraception [oral contraceptive pill (OCP), depot medroxyprogesterone acetate (DMPA; brand name Depo-Provera) injection, implants, intrauterine device (IUD), and morning after pill], along with total number of pregnancies and live births.
Ophthalmic Examination
Participants completed an ophthalmic assessment that included postcycloplegic autorefraction (Nidek ARK-510A Auto Refractometer, Nidek Co Ltd, Japan), IOP (ICare TAO1i Rebound Tonometer, ICare Finland Oy, Vantaa, Finland), central corneal thickness (Oculus Pentacam, OCULUS Optikgeräte GmbH, Wetzlar, Germany), and spectral-domain optical coherence tomography (SD-OCT; Spectralis HRA+OCT, Heidelberg Engineering, Heidelberg, Germany), a frequency-based image acquisition system. The detailed SD-OCT image acquisition method has been described previously. 21 Parameters measured by SD-OCT included the neuroretinal rim (NRR) area and its horizontal and vertical widths, along with the cup and Bruch membrane opening (BMO) horizontal and vertical widths. As the BMO provides a better indication of the NRR anatomical outer border than the disc margin, 24 we used the BMO dimensions as a surrogate for optic disc, and the vertical and horizontal cup-todisc (C/D) ratios were calculated. Analyses involving C/D ratios were adjusted for BMO widths. 25 
Statistical Analysis
Age at menarche was described as a continuous variable and also as a categorical variable grouped into less than 13 years, 13 years, and 14 years or older, similar to the categories used in previous studies 11, 12 that have found significant associations between later age at menarche and increased glaucoma incidence in older women.
The relationship between the various female reproductive factors and optic disc parameters was analyzed using Generalized Estimating Equations (GEEs), which account for missing data and the nonnormal distribution of the data, as well as allowing adjustments for covariates. An exchangeable correlation structure was used to account for the within-subject correlation between the 2 eyes. 26 Each factor was entered as an independent variable into separate GEE models, with each optic disc parameter as the outcome measure. Univariate analyses were first conducted, then if statistically significant, multivariate analyses were performed to correct for covariates and possible confounding factors. All statistical analyses were conducted in R version 3.4.0 [2017 The R Foundation for Statistical Programming, https://www.r-project.
org/ (open-source)]. The level of significance was set at 0.05, but due to multiple comparisons, a Bonferroni adjustment was applied. P values less than or equal to 0.007 were thus considered statistically significant (based on 7 analyses conducted on each dependent variable).
RESULTS
Of the 654 women who attended the session, 45 did not complete SD-OCT measurements and a further 115 did not provide information on their pubertal and reproductive health. The remaining 494 women, with a mean age of 20.0 years (SD, 0.4; range, 18.3-21.8 years) and of predominantly white ethnicity, were included in the analysis.
The mean age at menarche was 12.8 years (SD, 1.1 years; range, 9.2-15.9 years). A majority of the participants were using or had used at least 1 form of hormonal contraceptive, including OCP (284, 57.5%), morning after pill (63, 12.8%), implants (38, 7.7%), DMPA injections (12, 2.4%), and IUD (3, 0.6%). Given the small number of participants who used IUDs, the effect of this hormonal contraceptive was not analyzed but nonetheless corrected as a possible confounder in multivariable analyses. There were 180 women (36.4%) who had never used any hormonal contraceptive. Most participants reported never having been pregnant (93.1%), 27 (5.5%) had 1 pregnancy, and 7 (1.4%) had 2 or more pregnancies. Ten participants had 1 live birth (parous women, 2.0%) and the rest were nulliparous (never pregnant, had early termination of pregnancy, or miscarriage; n = 484, 98.0%). Given that hormonal effects are greater with parity than pregnancy itself, 27 and as the number of pregnancies and number of live births are closely related, only the difference between nulliparous women and those who had given birth (parous women) was analyzed.
As shown in Table 1 , parous women had significantly larger vertical and horizontal NRR widths compared with nulliparous women (χ (Table 1) . Table 2 provides a summary of the ocular characteristics and use of hormonal contraceptive for the parous and nulliparous women.
None of the other female reproductive factors, including age at menarche (whether as a categorical or continuous variable), duration of menstrual cycle, and use of any of the hormonal contraceptives, were significantly associated with any optic disc parameter (P > 0.007). Other ocular associations of glaucoma, including refractive error, IOP, and central corneal thickness, also did not have any significant relationship with female reproductive factors (P > 0.007).
DISCUSSION
In this cohort of young women, we found limited associations between female reproductive factors and glaucoma-related optic disc parameters. Although interestingly, we found that parous women had larger vertical NRR widths than nulliparous women, which would be inherently related to smaller C/D ratios, as we also observed.
It is important to note that our findings on the optic disc parameters in parous young women do not imply that parity is directly related to a decreased risk of glaucoma, rather, only those parous women possess optic disc traits that are desirable in the context of a lower risk of the disease. However, this finding is incompatible with that of the Blue Mountains Eye Study, 11 which reported that parity is associated with an increased risk of open-angle glaucoma, whereas another population-based study by Pasquale and Kang 12 found a null relationship between the 2 measures. The mechanisms underlying the positive (or negative) effect of parity on optic nerve integrity are unclear. Theoretically, a parous woman may have benefited from the temporary reduction in IOP and elevated hormonal levels during her pregnancy, 4, 5, 28 which are believed to be beneficial for optic nerve integrity. 4, 5 Even though IOP and hormonal levels typically revert to near-prepregnancy values postpartum, 28 any effect on the optic nerve and optic disc structure may be long-term. However, for this current cohort of women, this reasoning is unlikely given their young age and relatively healthy eyes. On the other hand, in the Blue Mountains Eye Study, Lee et al 11 speculated that plasma cortisol levels may be elevated during parturition, which could impede aqueous outflow in susceptible parous women, thus increasing the risk of open-angle glaucoma. These conflicting findings and complex mechanisms by which pregnancy and parturition may affect the eye indicate that there is still much to learn about the link between parity, optic disc, and risk of glaucoma. To better address this issue, follow-up studies of this cohort are underway and will enable us to compare NRR and other glaucoma-related optic disc parameters before and after parity. Age at menarche was not associated with any optic disc parameters in young women. Although there has been no prior research which can be compared with the current finding, there have been a few studies on the relationship between age at menarche and glaucoma risk, although the outcomes were conflicting. Population-based studies in Australia 11 and the United States 12 reported that women who experienced menarche at an older age (13 years or older) were up to twice as likely to develop glaucoma later in life compared with those who had menarche at a younger age.
Conversely, Nirmalan et al 29 failed to find a link between age at menarche and glaucoma risk in a rural South Indian population. However, it should be noted that the null finding by Nirmalan et al 29 may be related to their relatively younger population sample (by more than 10 years) and older mean age at menarche (by approximately 1.5 years) compared with the other studies. 11, 12 The difference in population ethnicity between studies may also partly explain the discrepancy in findings. Given the limited and conflicting findings, the relationship between age at menarche and glaucoma risk should be further investigated. Future followup of this cohort of young women in our current study will allow us to explore this when they are at an older age and when any optic disc changes as a result of age at menarche are more likely to have manifested.
The use of hormonal contraceptives was also not found to be associated with optic disc parameters. There is currently a lack of understanding on the ocular effects of hormonal contraceptives, particularly the less frequently used types such as DMPA and implants. The use of OCPs is more common and there have been reports of a 25% to 94% increase in glaucoma risk with long-term (3 years or more) use. 14, 30 Given that most OCPs contain high levels of estrogens and progesterone, which have neuroprotective effects, 6 a link to increased glaucoma risk seems paradoxical. A possible explanation for this relationship, as postulated by Wang et al, 30 is that the use of OCPs disrupts the natural menstrual cycle, during which the physiological variations in hormonal levels play a role in ocular neuroprotection. However, we did not find that the use of OCPs was related to any optic disc parameters in our sample of young women. Given that this cohort would only have been exposed to the effects of OCPs for a relatively short time, any influence of long-term OCP use may not yet be apparent. Furthermore, the influence of hormonal contraception on levels of sex steroids varies even within similar classes of contraception (eg, OCPs may be progestin-only or combined estrogen and progestogen, whereas IUDs may or may not be progestin-releasing). In view of the complex relationship between hormonal contraception and level of female sex steroid exposure, the influence of these factors on optic disc parameters is worthy of further investigation.
In considering the outcome of this study, we have to take its strengths and limitations into account. A strength of our method of data collection was that the information on female reproductive factors, including age at menarche, was obtained during participants' adolescence and young adulthood, compared with previous studies that only obtained this information during middle age or later and thus were subject to greater recall error. Another strength was the use of SD-OCT to image the optic disc in high resolution, which allowed us to detect subtle preclinical changes in the optic disc. However, even with SD-OCT imaging, we were only able to identify limited influences of female reproductive factors on the optic disc. This may be partly due to the relatively small number of women in the various subgroups (hormonal contraceptives use, parity) in this cohort, which is the main limitation of the study. Furthermore, our dataset did not allow us to account for the effect of hormonal fluctuations that occur during the normal menstrual cycle, which has previously been suggested to influence optic disc parameters.
31
In summary, we found no evidence that age at menarche and use of hormonal contraceptives are associated with optic disc parameters in young women and thus are unable to predict glaucoma risk later in life based on these factors, at least up to the second decade. Although we found that parity is associated with some optic disc parameters, this outcome should be interpreted conservatively given the small number of parous women in the current sample. At the time of this OCT measurement, those women who had children were young mothers. In Australia, only about 15% of new mothers would be less than 25 years of age, and over 60% of new mothers would be 25 to 34 years old. 32 It is possible that any influence of female reproductive factors and sex steroids on optic disc parameters will only start to manifest when women are at an older age; this shall be explored as we follow this cohort through their later decades.
